8d
Under30CEO on MSNBuffett maintains confidence in Apple investmentWarren Buffett has decided to keep his Apple shares unchanged through the fourth quarter. The billionaire’s Berkshire ...
Wildix, a 100 percent channel-driven provider of AI-powered UCaaS, announced several key leadership appointments to fuel ...
After delivering 31% Annual Recurring Revenue (ARR) growth and maintaining an industry-leading 94% customer retention rate, Wildix is expanding its leadership team to accelerate innovation, deepen its ...
March 4 (Reuters) - Cybersecurity firm Crowdstrike (CRWD.O), opens new tab forecast first-quarter revenue slightly below estimates, as it grapples with weak spending on its cybersecurity products.
Feb, 26 (UPI) --Despite the best of intentions, unless the trajectory of the Department of Government Efficiency is reversed as it descends on the Pentagon, it will not achieve its goals of ...
In 2020, Eats became central to sustaining the business, as Uber’s ride hailing platform saw 50 percent less revenue than a year ago. That reversed in 2022 with mobility leading the way in revenue and ...
The UK was one of the first countries to recognise them as such. The coronavirus pandemic hit Uber’s ride hailing business hard, but by Q4 2020 it had reached pre-pandemic revenue figures. Uber Eats ...
Donald Trump Jr. made $813,000 in 2024 as a director of Trump Media & Technology Group—roughly a quarter of the company’s annual revenue—despite attending just two of the board’s five ...
It could be an attempt to broaden revenue streams, plot the location of a future store or, at its simplest, take advantage of a good deal.
There were 24 GCCs surpassing the $1 billion export revenue mark in financial year 2023-24, up from 19 in the previous year, according to research by Pune-based consultancy Wizmatic. These 24 ...
Kerala Chief Minister Pinarayi Vijayan emphasizes revenue generation without burdening the people while highlighting the state's strong economic growth despite lower central funds. Kochi, Feb 24 (PTI) ...
Of the world’s 22 biopharma companies that had reported quarterly revenue of at least $2 billion by Feb. 24, only one posted a year-over-year decline. And that decrease had a caveat. Teva saw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results